2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread. - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2004

2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread.

Jeffrey J Bajramovic
  • Fonction : Auteur
Romain Volmer
  • Fonction : Auteur
Sylvie Syan
  • Fonction : Auteur
Sylvie Pochet
  • Fonction : Auteur

Résumé

Borna disease virus (BDV) causes neurological diseases in a variety of warm-blooded animal species, possibly including humans. To date, there is no effective treatment against BDV infection. Recently, we reported on the antiviral activity of 1-beta-D-arabinofuranosylcytosine (Ara-C). However, Ara-C's cytotoxic side effects are a major obstacle for its therapeutic use. Herein, we demonstrate that the nucleoside analog 2'-fluoro-2'-deoxycytidine (2'-FdC) exhibits potent antiviral activity against BDV. Importantly, 2'-FdC-associated cytotoxicity is negligible, indicating 2'-FdC as an excellent candidate for the development of antiviral therapy against BDV.

Domaines

Autre [q-bio.OT]

Dates et versions

pasteur-00166243 , version 1 (02-08-2007)

Identifiants

Citer

Jeffrey J Bajramovic, Romain Volmer, Sylvie Syan, Sylvie Pochet, Daniel Gonzalez-Dunia. 2'-fluoro-2'-deoxycytidine inhibits Borna disease virus replication and spread.. Antimicrobial Agents and Chemotherapy, 2004, 48 (4), pp.1422-5. ⟨10.1128/AAC.48.4.1422-1425.2004⟩. ⟨pasteur-00166243⟩
99 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More